Mitchel Markins, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1533 Charmuth Rd, Lutherville, MD 21093 Phone: 410-832-5775 |
Mr. Stephen Wesley Wilson, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10751 Falls Rd, Suite 425, Lutherville, MD 21093 Phone: 410-583-2760 Fax: 410-583-2759 |
Jan Hetherington, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 10751 Falls Rd, Falls Road Concourse Suite 425, Lutherville, MD 21093 Phone: 410-583-2760 |
Mr. Herbert Ralph Zinder, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1205 York Rd, Ste 390, Lutherville, MD 21093 Phone: 410-825-6652 Fax: 410-825-6654 |
News Archive
Both studies appear in the September issue of Neuropsychology, which is published by the American Psychological Association (APA). Psychologists focus on early detection in part because current medications are useful only when given very early in the course of the disease.
Omeros Corporation today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance on a battery of tests in patients with symptomatic HD.
A diet designed to improve cardiovascular health is associated with improved cognitive maintenance in old age, say researchers. The finding comes from four large-scale, population-based studies that were reported on at the 2017 Alzheimer's Association International Conference (AAIC) in London.
Investigators will begin offering Gleevec(R) (imatinib mesylate)* tablets to patients receiving placebo in a major North American clinical trial after an interim analysis showed participants with Kit-positive gastrointestinal stromal tumors treated with Gleevec following surgery were significantly less likely to experience a return of their cancer compared to those not taking this innovative therapy.
› Verified 3 days ago